Advertising

The Seattle Times Company

NWjobs | NWautos | NWhomes | NWsource | Free Classifieds | seattletimes.com

The Seattle Times

Health


Our network sites seattletimes.com | Advanced

Originally published July 13, 2007 at 12:00 AM | Page modified July 13, 2007 at 2:04 AM

E-mail article     Print view

Usage of morning-after pill surges and so does controversy

The popularity of the morning-after pill Plan B has surged in the year since the federal government approved the sale of the emergency contraceptive...

The Washington Post

WASHINGTON — The popularity of the morning-after pill Plan B has surged in the year since the federal government approved the sale of the emergency contraceptive without a prescription.

Plan B sales have doubled since the Food and Drug Administration authorized the switch for women 18 and older last August, rising from about $40 million a year to what will probably be close to $80 million for 2007, according to Barr Pharmaceuticals, which makes Plan B.

The sharp rise was hailed by women's health and family-planning advocates, who say it illustrates the value of easing access to birth control to help prevent unwanted pregnancies.

"This is exactly what we hoped would happen," said Susan Wood of the George Washington University School of Public Health. As assistant commissioner for women's health and director of the Office of Women's Health at the FDA, Wood pushed for the switch. "What we're seeing is women who needed this product now finally having access to it. For a woman in that position, it can make a real difference in her life."

But conservative groups that fought the change say they are disturbed by the surging use. "This is very concerning," said Charmaine Yoest of the Family Research Council, which is among several groups suing the FDA to reverse the decision. "We think this is putting women's health at risk."

Plan B consists of higher doses of the hormones found in standard birth-control pills. Taken within 72 hours of unprotected sex, Plan B has been shown to be highly effective at preventing pregnancies. Despite endorsements by outside advisers and internal reviewers, the FDA delayed for three years making it available without a prescription, leading to intense criticism that the agency was allowing politics to influence the decision.

The Aug. 25 ruling that finally permitted the change was criticized both by conservatives and by proponents, who were disappointed that the agency limited the easier availability to women 18 and older. The agency said there was too little safety data to approve the drug for teenagers younger than 18.

Surveys and anecdotal reports indicate some pharmacies refuse to stock the drug, some pharmacists refuse to provide it, and some pharmacy workers mistakenly believe only the pharmacist can dispense the drug.

Copyright © 2007 The Seattle Times Company

More Health headlines...

E-mail article Print view      Share:    Digg     Newsvine

advertising

Big demand, grim outlook for state Basic Health Plan

Trying last-ditch lung bypass for worst swine flu

UPDATE - 06:31 PM
Comatose for 23 years, Belgian feels reborn

Vaccine to kill nicotine buzz now in late tests by small drug firm

Cutting through breast-cancer confusion

Advertising

Video

New Beginnings Christian Fellowship
Coming in this Sunday's Pacific Northwest Magazine: Pastor Braxton's mission is to preach a message that appeals to everyone.

PNW Magazine | Easy As Pie
Real Salt Lake wins MLS Cup
Raw Video | Real Salt Lake fans celebrate
Raw Video | Real Salt Lake receives the MLS Cup trophy
Raw Video | MLS Cup Opening Ceremony
Real Salt Lake fans enter Qwest Field
LA Galaxy's David Beckham
Real Salt Lake's Kyle Beckerman
MLS trophy arrives in Seattle

Marketplace

Open Houses

Find this weekend's open house listings.
Or search by location:

nwautos

Less is more: Group rides, good gas mileage have led to a scooter swarm in Seattlenew
Local riders say they've seen a surge in scooter interest in recent years, mostly from people wanting another commuting option. Seattle now ranks as o...
Post a comment

 
Most read
Most commented
Most e-mailed
 
 
Advertising